Randomized double-blind clinical trial of a new human epoetin versus a commercially available formula for anemia control in patients on hemodialysis

OBJECTIVES: Anemia is a common complication among chronic kidney disease patients on hemodialysis, occurring mostly due to erythropoietin deficiency. This randomized noninferiority trial sought to compare the efficacy and safety of a new epoetin formulation developed by Bio-Manguinhos, a biologics m...

Descripción completa

Detalles Bibliográficos
Autores principales: Picon, Paulo D., Pribbernow, Suzane Cristina M., Prompt, Carlos A., Schacher, Suzana C., Antunes, Veronica V. H., Mentz, Bianca P., Oliveira, Fabiane L., de Souza, Celia Mariana B., Schacher, Fernando C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2014
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129558/
https://www.ncbi.nlm.nih.gov/pubmed/25141114
http://dx.doi.org/10.6061/clinics/2014(08)08

Ejemplares similares

Ejemplares similares